Navigation Links


GmbH in Biological Products

Lumat Singel Tube Luminometer LB 9507 from BERTHOLD TECHNOLOGIES GmbH & Co. KG

Description: The Lumat tube luminometer provides the sensitivity and versatility you expect from a general purpose luminometer. Advanced digital photon counting with selected photomultipliers ensure superior sensitivity and best match of spectral demands. Equipped with up to 2 reagent injectors the Lumat is ide...
Company:BERTHOLD TECHNOLOGIES GmbH & Co. KG

NightOWL II LB 983 NC100 from BERTHOLD TECHNOLOGIES GmbH & Co. KG

Description: NightOWL is a dedicated imaging system for detection of very low level of luminescent light due to pixel size. Equipped with an extreme sensitive camera to detect low level light in animals or plants in tumor research, infectious disease research, gene expression, circadian rhythm or Western blots....
Company:BERTHOLD TECHNOLOGIES GmbH & Co. KG

NightOWL II LB 983 NC320 from BERTHOLD TECHNOLOGIES GmbH & Co. KG

Description: NightOWL is a dedicated imaging system for fluorescent light due to small pixel size. Equipped with a very sensitive camera to detect low level light in animals or plants in tumor research, infectious disease research, gene expression, circadian rhythm, gels and Western blots. NightOWL is the only ...
Company:BERTHOLD TECHNOLOGIES GmbH & Co. KG

Human, Bovine, Porcine, Rat VIP, aa 6-28 from Biotrend Chemikalien GmbH

Description: VIP (6-28) (human, bovine, porcine, rat) Vasoactive Intestinal Peptide (VIP) receptor antagonist. This carboxy-terminal VIP fragment was found to be twofold more potent than any previously described VIP receptor antagonists. Storage: Desiccate at -20 C...
Company:Biotrend Chemikalien GmbH

Rosmarinic acid from Biotrend Chemikalien GmbH

Description: Antiinflammatory, cytostatic and anti-viral agent. Inhibits several important steps of angiogenesis including proliferation, migration, adhesion and tube formation of HUVEC cells. Also reduces intracellular reactive oxygen species (ROS) level, H(2)O(2)-dependent VEGF expression and IL-8 release of ...
Company:Biotrend Chemikalien GmbH

Human, Porcine Endothelin-1 from Biotrend Chemikalien GmbH

Description: Endothelin-1 (human, porcine) Endogenous potent vasoconstrictor peptide. Displays selectivity for the endothelin ETA receptor and modulates vascular tonus. ET-1, ET-2, and ET-3 are the products of three distinct endothelin genes. ET-2 and ET-3 are similar to ET-1, but differ in two and six amino ...
Company:Biotrend Chemikalien GmbH

StrepMAB-Immo coated microplate; 96 well from IBA GmbH

Description: The new StrepMAB-Immo coated microplates can be used for efficient, mild and oriented immobilization of SerAla-Strep-tag II fusion proteins for ELISA or other assays for protein analysis. Also small amounts of such proteins are bound with high efficiency to the microplate (see graphic on the left) ...
Company:IBA GmbH

Etoposide from Biotrend Chemikalien GmbH

Description: Antitumour agent and DNA-topoisomersae II inhibitor (IC50 = 59.2 M). Formula: C 29 H 32 O 13 MolWeight: 588.55658 Store at: RT CAS: 33419-42-0 Solubility: Soluble to 100 mM in DMSO IUPAC: [5R-[5alpha,5abeta,8aalpha,9beta(R*)]]-9-[(4,6-O-Ethylidene-beta-D-glucopyrano...
Company:Biotrend Chemikalien GmbH

* Quick & Easy E. coli Gene Deletion Kit from Gene Bridges GmbH

Description: This kit is designed to knockout or alter genes on the E.coli chromosome in less than one week. Red/ET recombination allows the exchange of genetic information in a base pair precise, specific, and faithful manner. An FRT-flanked kanamycin resistance marker cassette is supplied with the kit which...
Company:Gene Bridges GmbH

Mynox Mycoplasma Elimination Reagent from Minerva Biolabs GmbH

Description: Mynox is the first biological reagent that eliminates mycoplasmas by killing them, and not just by inhibiting growth. Mynox is the only anti-mycoplasma agent that can be used to clean virus stocks directly. The cytotoxicity of Mynox is extremely low....
Company:Minerva Biolabs GmbH

loxP flanked Ampicillin Selection Cassette (loxP-amp-loxP) from Gene Bridges GmbH

Description: The loxP-amp-loxP cassette is designed to allow ampicillin selection in prokaryotic cells. The prokaryotic promoter gb2 driving the gene for ampicillin resistance is a slightly modified version of the Em7 promoter. It mediates higher transcription efficiency than the generally used Tn5 promoter....
Company:Gene Bridges GmbH

FRT flanked Ampicillin Selection Cassette (FRT-amp-FRT) from Gene Bridges GmbH

Description: The FRT-amp-FRT cassette is designed to allow ampicillin selection in prokaryotic cells. The prokaryotic promoter gb2 driving the gene for ampicillin resistance is a slightly modified version of the Em7 promoter. It mediates higher transcription efficiency than the generally used Tn5 promoter. A...
Company:Gene Bridges GmbH

* Quick & Easy Conditional Knock Out Kit - FRT from Gene Bridges GmbH

Description: This kit is designed for the fast and simple integration of FRT-sites into large vector plasmids at any position (for the generation of transgenic mouse models). The included FRT-PGK-gb2-neo-FRT cassette is designed to allow neomycin / kanamycin selection in prokaryotic and eukaryotic cells. It com...
Company:Gene Bridges GmbH

loxP flanked Chloramphenicol Selection Cassette (loxP-cm-loxP) from Gene Bridges GmbH

Description: The loxP-cm-loxP cassette is designed to allow chloramphenicol selection in prokaryotic cells. The prokaryotic promoter gb2 driving the gene for chloramphenicol resistance is a slightly modified version of the Em7 promoter. It mediates higher transcription efficiency than the generally used Tn5 ...
Company:Gene Bridges GmbH

* Quick & Easy Conditional Knock Out Kit - loxP from Gene Bridges GmbH

Description: This kit is designed for the fast and simple integration of loxP-sites into large vector plasmids at any position (for the generation of transgenic mouse models). The included loxP-PGK-gb2-neo-loxP cassette is designed to allow neomycin / kanamycin selection in prokaryotic and eukaryotic cells. It ...
Company:Gene Bridges GmbH

FRT flanked, Pro and Euk. Neomycin Selection Cassette plus loxP site(FRT-PGK-gb2-neo-FRT-loxP) from Gene Bridges GmbH

Description: The FRT-PGK-gb2-neo-FRT-loxP template is designed to allow kanamycin/neomycin selection in prokaryotic and eukaryotic cells, respectively. It combines a prokaryotic promoter (gb2) for expression of kanamycin resistance in E.coli with a eukaryotic promoter (PGK) for expression of neomycin resis...
Company:Gene Bridges GmbH

loxP flanked, Pro and Euk. Neomycin Selection Cassette (loxP-PGK-gb2-neo-loxP) from Gene Bridges GmbH

Description: The loxP-PGK-gb2-neo-loxP template is designed to allow neomycin/kanamycin selection in prokaryotic and eukaryotic cells. The loxP-PGK-gb2-neo-loxP template encodes the neomycin/kanamycin resistance gene which combines a prokaryotic promoter (gb2) for expression of kanamycin resistance in E.coli w...
Company:Gene Bridges GmbH

FRT flanked, Pro and Euk. Neomycin Selection Cassette (FRT-PGK-gb2-neo-FRT) from Gene Bridges GmbH

Description: The FRT-PGK-gb2-neo-FRT template is designed to allow neomycin/kanamycin selection in prokaryotic and eukaryotic cells. The FRT-PGK-gb2-neo-FRT template encodes the neomycin/kanamycin resistance gene which combines a prokaryotic promoter (gb2) for expression of kanamycin resistance in E.coli w...
Company:Gene Bridges GmbH

Taq DNA Polymerase -Klein Taq from AppliChem GmbH

Description: Klein Taq is a derivative of Taq DNA polymerase. It is a 5'-exo-minus N-terminally truncated Thermus aquaticus DNA polymerase. Expressed from a gene construct in E. coli, translation initiates at Met236, bypassing the 5'-3' exonuclease domain of the DNA polymerase-encoding gene. The enzyme reveals ...
Company:AppliChem GmbH

Dithio-bis(2-nitrobenzoic acid) BioChemica from AppliChem GmbH

Description: Synonym: Dinitro-5,5'-dithiodibenzoic acid , DTNB , Ellman's reagent *M: 396.36 g/mol *CAS-No.: 69-78-3 *Storage: RT When an enzyme-catalyzed reaction creates a product with a reactive grouping not present in the substrate, it may be possible to include a reagent which will react direc...
Company:AppliChem GmbH

MATra-si Reagent for 200g nucleic acids from IBA GmbH

Description: MATra-si Reagent optimized for siRNA applications, contains magnetic nanoparticles (MagTag) which can be loaded with the nucleic acid of interest. Exploiting magnetic force the full nucleic acid dose is then rapidly drawn towards and delivered into the target cells leading to efficient transfection...
Company:IBA GmbH

Leukocytes, human - sonicated from AppliChem GmbH

Description: NOTE: 0.9 ml per liter of urine will give a positive reaction for leukocytes on an Ames or BMD dipstick. Certification: The Donors are of US origin and have been tested and found to be NEGATIVE for HbsAg, HCV, HIV-1 & 2, Syphilis and HIV-1 Antigen by currently approved FDA methods. THIS MATERIAL ...
Company:AppliChem GmbH

CromoCenAGN SC - Powder with supplement A5012 from AppliChem GmbH

Description: CromoCenSC is a chromogenic medium for the detection, isolation, differentiation and/or count of Salmonella (except S. thyphi) and total coliforms from other Gram-negative bacteria. The detection takes a maximum of 24 hours, needs no additional biochemical tests, no sterilization during preparatio...
Company:AppliChem GmbH

Denhardt's powder mixture (for 50X stock solution) from AppliChem GmbH

Description: Denhardt's powder mixture (for 50X stock solution)...
Company:AppliChem GmbH

TNM-FH - Insect medium (modified Grace's Insect medium) from AppliChem GmbH

Description: Synonym: modified Grace's Insect medium...
Company:AppliChem GmbH

Schneider's Drosophila - Insect medium from AppliChem GmbH

Description: Schneider's Drosophila - Insect medium...
Company:AppliChem GmbH

DNAscope AT from Biomedical Photometrics Inc.

Description:... 'A New Concept in Microarrays: Biomedical Photometrics Inc. (Waterloo, Ontario, Canada) and CLONDIAG chip technologies gmbh (Jena, Germany) have collaborated to develop a fluorescence reader for the new CLONDIAG ArrayTube System. The DNAscope AT is based on BPIs patented M...
Company:Biomedical Photometrics Inc.
Other TagsACCELACCELACCELFordFordFordFordliteracymodemodemodemodemodemode
(Date:11/30/2009)... , CLEMSON Clemson University researchers Ron Fa...vironmental Protection Agency grant to study the s...ions located deep below the earth,s surface. , W...uels believed to be the leading cause of global wa...ost promising alternatives for reducing emissions ...
(Date:11/30/2009)... HOUSTON (Nov. 30, 2009) Scientists and engineer...icine and energy will come together Dec. 7 with l...ving oil and pumping blood. , Much like moving o...hrough the body. Both systems need clean, well-fu...ges or corrosion, to function efficiently. Both in...
(Date:11/30/2009)... Take advantage of lower early bird registration ...eoporosis congress of 2010 at http://www.iofwco-e... congress of the International Osteoporosis Founda...nd Economic Aspects of Osteoporosis and Osteoarthr...ound the world are expected to attend. The excitin...
Breaking Biology News(10 mins):Similarities of pumping blood and oil examined 2Similarities of pumping blood and oil examined 3Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 1Accumetrics Inc Announces Distribution Channels in Israel and Cyprus 48302 2ThermoGenesis Announces National Institute of Health Grant 4576 1ThermoGenesis Announces National Institute of Health Grant 4576 2ThermoGenesis Announces National Institute of Health Grant 4576 3ThermoGenesis Announces National Institute of Health Grant 4576 4New antibiotics could come from a DNA binding compound that kills bacteria in 2 minutes 48295 1New antibiotics could come from a DNA binding compound that kills bacteria in 2 minutes 48295 2
(Date:12/2/2009)... Award-winning author James...l-length book, Short White Coat: Lessons from Pati...th through the third year of medical school--the g...PHILADELPHIA, PA (PRWEB) December 2, 2009 -- Most...d themselves dressed in a tiny hospital gown or st...
(Date:12/2/2009)..., , SAN DIEGO, Dec. 2 /PRNewswire-FirstCall...present at the 21st Annual Piper Jaffray Health Ca... presentation is scheduled to be webcast live and ...ction of Gen-Probe,s website at www.gen-probe.com...wing the event. ,, About Gen-Probe ,, Gen...
(Date:12/2/2009)..., , JOHANNESBURG, Dec. 2 Le...(over US$6 million) investment in AllLife, the inn...g with HIV and diabetes. The investment brings tog...ent fund, and AllLife, one of Africa,s most innova...lace after World AIDS Day. ,, "AllLife has deve...
(Date:12/2/2009)...CHICAGO Results of a large-scale clinical trial p...ogical Society of North America (RSNA) provide the...reening ultrasound for women with dense breasts wh...ion, the study confirmed that MRI is highly sensit...d that annual screening with ultrasound in additio...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 R...ch report is available in its catalogue: ,, Th...eutics - Market Forecasts to 2015, Competitive Ben..., http://www.reportlinker.com/p0166814/The-Futu...---Market-Forecasts-to-2015-Competitive-Benchmarki...
Breaking Medicine News(10 mins):Health News:Beneath the Short White Coat: A Medical Student Reveals All 2Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Annual screening with breast ultrasound or MRI could benefit some women 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
Other Contentsmorphologymorphologymorphologymorphologymorphologymossmosaicismmotifmotifmotifmotifmotormotormotormotormotormotormotormotormotormucosamucosamucosamucosamucosafamilyfamilyfamilyfamilyfamilyfamilyfamilyfamilyfamilyfamily